Finance

Beta
Lists
4572:TYO
Carna Biosciences, Inc.
390,00 JPY
-8,45%
(-36,00) 1D
8 ივნ, 15:30:00 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4572...
Open
413 JPY
High
418 JPY
Low
380 JPY
Mkt. cap
7,71 მლრდ.
Avg. vol.
203,49 ათ.
Volume
333,80 ათ.
52-wk high
512 JPY
52-wk low
200 JPY
EPS
-114 JPY
Shares outstanding
10,14 მლნ.
No. of employees
61
Open
413 JPY
High
418 JPY
Low
380 JPY
Mkt. cap
7,71 მლრდ.
Avg. vol.
203,49 ათ.
Volume
333,80 ათ.
52-wk high
512 JPY
52-wk low
200 JPY
EPS
-114 JPY
Shares outstanding
10,14 მლნ.
No. of employees
61
News stories
From sources across the web
About Carna Biosciences, Inc.
CEO-
Employees61
Founded10 აპრ. 2003
Headquarters-
SectorHealth care
Websitecarnabio.com
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
ივნ. 2025
სექ. 2025
დეკ. 2025
მარ. 2026
Revenue
107,65 მლნ.
144,33 მლნ.
183,57 მლნ.
183,64 მლნ.
Cost of goods sold
33,46 მლნ.
47,38 მლნ.
66,26 მლნ.
52,35 მლნ.
Cost of revenue
33,46 მლნ.
47,38 მლნ.
66,26 მლნ.
52,35 მლნ.
Research and development expenses
-
-
1,85 მლრდ.
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
628,91 მლნ.
595,96 მლნ.
-1,21 მლრდ.
589,72 მლნ.
Operating expense
628,91 მლნ.
595,96 მლნ.
640,46 მლნ.
589,72 მლნ.
Total operating expenses
662,37 მლნ.
643,35 მლნ.
706,72 მლნ.
642,07 მლნ.
Operating income
-554,72 მლნ.
-499,01 მლნ.
-523,14 მლნ.
-458,44 მლნ.
Other non operating income
-1,92 მლნ.
-39,00 ათ.
-770,00 ათ.
369,00 ათ.
EBT including unusual items
-557,09 მლნ.
-543,38 მლნ.
-571,28 მლნ.
-512,11 მლნ.
EBT excluding unusual items
-557,23 მლნ.
-535,04 მლნ.
-555,94 მლნ.
-488,97 მლნ.
Income tax expense
-149,00 ათ.
572,00 ათ.
-287,00 ათ.
1,12 მლნ.
Effective tax rate
0,03%
-0,11%
0,05%
-0,22%
Other operating expenses
-
-
-
-
Net income
-556,94 მლნ.
-543,95 მლნ.
-570,99 მლნ.
-513,24 მლნ.
Net profit margin
-517,34%
-376,88%
-311,05%
-279,49%
Earnings per share
-
-
-
-
Interest and investment income
907,00 ათ.
993,00 ათ.
-
932,00 ათ.
Interest expense
-540,00 ათ.
-33,90 მლნ.
-17,72 მლნ.
-13,19 მლნ.
Net interest expenses
367,00 ათ.
-32,91 მლნ.
-17,72 მლნ.
-12,25 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-546,96 მლნ.
-491,20 მლნ.
-515,40 მლნ.
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer